Evidence map›Paper›PMID 37943312›Full record

ArticleEuropean radiology2024

Quantitative T

James G Harper, Elizabeth N York, Rozanna Meijboom, Agniete Kampaite, Michael J Thrippleton, Patrick K A Kearns, Maria Del C Valdés Hernández, Siddharthan Chandran, Adam D Waldman, FutureMS consortium

Open access · hybridAbstract read
In one paragraph

Article in European radiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Abdominal TMagma (New York, N.Y.) · 2026
    Article
  2. Field Strength-Dependent White Matter RMagnetic resonance in medicine · 2026
    Article
  3. Structure-preserving Image-quality Enhancement for 3D Synthetic FLAIR Using a 3D U-Net with Content and Style Losses.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

James G HarperCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.ORCID http://orcid.org/0000-0003-3520-6060
Elizabeth N YorkCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK. eyork@ed.ac.uk.ORCID http://orcid.org/0000-0002-4310-8607
Rozanna MeijboomCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Agniete KampaiteCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Michael J ThrippletonCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Patrick K A KearnsCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Maria Del C Valdés HernándezCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Siddharthan ChandranCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK.
Adam D WaldmanCentre for Clinical Brain Sciences, University of Edinburgh, Edinburgh BioQuarter: Chancellors Building, Edinburgh, EH16 4SB, UK. adam.waldman@ed.ac.uk.
FutureMS consortium
University of Edinburgh · GBMRC Centre for Regenerative Medicine · GB

Funding

Chief Scientist Office, Scottish Government Health and Social Care Directorate MMPP/01Dunhill Medical Trust R380R/1114Edinburgh and Lothians Health Foundation 2012/17Mrs Gladys Row Fogo Charitable Trust BRO-D.FID3668413Multiple Sclerosis Society grant reference 133Wellcome TrustWellcome Trust 104916/Z/14/ZWellcome Trust 223058/Z/21/Z
6 · The paper itself

Abstract

objectivesTo quantify brain microstructural changes in recently diagnosed relapsing-remitting multiple sclerosis (RRMS) using longitudinal T

methodsSeventy-nine people with recently diagnosed (< 6 months) RRMS were recruited from a single-centre cohort sub-study, and underwent baseline and 1-year brain MRI, including variable flip angle T

resultsSixty-two people with RRMS (mean age 37.2 ± 10.9 [standard deviation], 48 female) and 11 healthy controls (age 44 ± 11, 7 female) contributed data. Prolonged and supramedian T

conclusionT CLINICAL RELEVANCE STATEMENT: MRI T KEY POINTS: • Quantitative T

Indexed as

Magnetic Resonance ImagingMultiple Sclerosis, Relapsing-RemittingAdultBrainBrain MappingDisability EvaluationFemaleGray MatterHumansLongitudinal StudiesMaleMiddle AgedWhite MatterBrainLongitudinal studiesMagnetic resonance imagingMultiparametric magnetic resonance imagingMultiple sclerosis (Relapsing-Remitting)

Identifiers

PMID37943312
PMCPMC11166797
OpenAlexW4388523734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.